CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 72 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2017. The put-call ratio across all filers is 2.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,250,000 | -69.0% | 247,450 | -62.5% | 0.01% | -73.5% |
| Q1 2018 | $4,030,000 | -14.1% | 660,714 | 0.0% | 0.03% | -17.1% |
| Q4 2017 | $4,691,000 | +472.1% | 660,714 | +407.7% | 0.04% | +485.7% |
| Q2 2017 | $820,000 | -23.6% | 130,129 | 0.0% | 0.01% | -22.2% |
| Q1 2017 | $1,074,000 | -51.1% | 130,129 | -50.0% | 0.01% | -59.1% |
| Q4 2016 | $2,198,000 | – | 260,129 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |